[HTML][HTML] Emerging roles of long non-coding RNAs as novel biomarkers in the diagnosis and prognosis of prostate cancer

Y Kan, B Li, D Yang, Y Liu, J Liu, C Yang… - Discovery …, 2021 - discoverymedicine.com
New biomarkers for early diagnosis and prognosis are important in improving the diagnosis
of metastatic or recurrent prostate cancer. Recent studies have shown important roles of …

[HTML][HTML] Oncogenic Long Noncoding RNAs in Prostate Cancer, Osteosarcoma, and Metastasis

A Al-Shehri, S Bakhashab - Biomedicines, 2023 - mdpi.com
Prostate cancer (PC) is a common malignancy and is one of the leading causes of cancer-
related death in men worldwide. Osteosarcoma (OS) is the most common bone cancer …

[HTML][HTML] Identification of specific long non-coding ribonucleic acid signatures and regulatory networks in prostate cancer in fine-needle aspiration biopsies

Z Li, J Zheng, Q Xia, X He, J Bao, Z Chen… - Frontiers in …, 2020 - frontiersin.org
Prostate cancer (PCa) is one of the most common tumors in men and can be lethal,
especially if left untreated. A substantial majority of PCa patients not only are diagnosed …

[HTML][HTML] The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis

W Ma, X Chen, L Ding, J Ma, W Jing, T Lan, H Sattar… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The abnormally expressed LncRNAs played irreplaceable roles in the prognosis of prostate
cancer (PCa). Therefore, we conducted this systematic review and meta-analysis to …

Long non-coding RNAs in prostate cancer: Functional roles and clinical implications

YH Xu, JL Deng, G Wang, YS Zhu - Cancer letters, 2019 - Elsevier
Long noncoding RNAs (lncRNAs) are defined as RNA transcripts longer than 200
nucleotides that do not encode proteins. LncRNAs have been documented to exhibit …

[HTML][HTML] The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management

VR Ramnarine, M Kobelev, EA Gibb, M Nouri, D Lin… - European urology, 2019 - Elsevier
Context It is increasingly evident that non–protein-coding regions of the genome can give
rise to transcripts that form functional layers of the cancer genome. One of most abundant …

Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer

C Zhang, C Liu, J Wu, Y Zheng, H Xu… - OncoTargets and …, 2017 - Taylor & Francis
Background/purpose Long noncoding RNAs (lncRNAs) play a functional role in the initiation
and progression of prostate cancer (PCa). This study aimed to determine differentially …

Re: Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome

A Atala - Journal of Urology, 2017 - journals.lww.com
Editorial Comment: Approximately 70% of the human genome is transcribed but less than
2% of the genome encodes protein. On the basis of size, noncoding RNAs can be classified …

[HTML][HTML] Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer

W Mo, J Zhang, X Li, D Meng, Y Gao, S Yang, X Wan… - PloS one, 2013 - journals.plos.org
MicroRNAs (miRNAs) have been recognized as significantly involved in prostate cancer
(PCa). Since androgen receptor (AR) plays a central role in PCa carcinogenesis and …

[HTML][HTML] Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer

N Shao, Y Zhu, FN Wan, DW Ye - Asian journal of andrology, 2019 - journals.lww.com
Accumulating evidence suggested that long noncoding RNAs (lncRNAs) possess a potential
role in prostate cancer (PCa) diagnosis and prognosis. Rapid biochemical recurrence (BCR) …